@article{Moorani_Zubair_Veerwani_Hotchandani_2020, title={Efficacy of Levamisole in children with Frequent Relapsing and Steroid Dependent Nephrotic Syndrome at Tertiary Care Center-Karachi}, volume={36}, url={https://pjms.org.pk/index.php/pjms/article/view/2337}, DOI={10.12669/pjms.36.6.2337}, abstractNote={<p><em><strong>Objectives:</strong> </em>To determine the effectiveness of levamisole in maintaining remission of proteinuria in children with frequent relapsing and steroid dependent nephrotic syndrome (FR/SDNS).</p> <p><em><strong>Methods:</strong></em> This observational study on 81 children with FR /SDNS was carried out from June 2007 - June 2017 at The Kidney Center-Postgraduate Training Institute, Karachi-Pakistan. Levamisole (leva) along with low dose prednisolone on alternate day (AD) was used after induction of remission with daily oral prednisolone in children with FR/ SDNS for 6-36 months. Patients with steroid resistance were excluded. Data was analyzed using descriptive statistics.</p> <p><em><strong>Results:</strong></em> Eighty-one patients with FR (66) or SD (15) received levamisole treatment. Mean age at diagnosis was 3.72 ±2.33 years. Levamisole was used on AD in 59.25% and daily in 40.74% of cases. Twenty-four could not complete six months and were excluded, 57 patients completed treatment duration of 15.68±9.93 months and 51 post-leva follow-up of 11.70±11.23 months. Mean cumulative prednisolone dose per patient before, on-leva and post-leva was 3389.81±2785.22, 2471.97±2024.98 and 661.37± 905.37 mg respectively. Mean relapse rate per year before leva, on -leva and post -leva was 3.30 ±0.50,0.98± 1.1and 0.79±1.27 respectively. Levamisole was effective in 90% of patients. During post-leva follow up, 76.4% patients, maintained remission, whereas 23.5% behaved as FR/SD and require further immunosuppressive therapy.</p> <p><em><strong>Conclusions:</strong></em> Levamisole was effective in maintaining remission in 90% while on treatment, whereas it maintained remission after discontinuation in 76.4% cases. Levamisole may be used as first steroid sparing agent before other immunosuppressive therapies in children with FR/SDNS. Further studies are required for optimal duration and dosage schedule.</p> <p><strong>doi: https://doi.org/10.12669/pjms.36.6.2337</strong></p> <p><em><strong>How to cite this:</strong></em><br>Moorani KN, Zubair AM, Veerwani NR, Hotchandani HJ. Efficacy of Levamisole in Children with Frequent Relapsing and Steroid Dependent Nephrotic Syndrome at Tertiary&nbsp;Care Center-Karachi. Pak J Med Sci. 2020;36(6):1193-1198.&nbsp;&nbsp;doi: https://doi.org/10.12669/pjms.36.6.2337</p> <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p&gt;}, number={6}, journal={Pakistan Journal of Medical Sciences}, author={Moorani, Khemchand Netaram and Zubair, Aasia Mohammad and Veerwani, Nanga Ram and Hotchandani, Harnam Jaichand}, year={2020}, month={Aug.} }